CDXS
Price:
$2.74
Market Cap:
$194.34M
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for ...[Read more]
Industry
Biotechnology
IPO Date
2010-04-22
Stock Exchange
NASDAQ
Ticker
CDXS
According to Codexis, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.49. This represents a change of -37.43% compared to the average of -3.98 of the last 4 quarters.
The mean historical PE Ratio of Codexis, Inc. over the last ten years is -38.22. The current -2.49 PE Ratio has changed 551.49% with respect to the historical average. Over the past ten years (40 quarters), CDXS's PE Ratio was at its highest in in the September 2019 quarter at 582.87. The PE Ratio was at its lowest in in the December 2018 quarter at -488.80.
Average
-38.22
Median
-21.92
Minimum
-94.88
Maximum
-2.73
Discovering the peaks and valleys of Codexis, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 377.46%
Maximum Annual PE Ratio = -2.73
Minimum Annual Increase = -90.45%
Minimum Annual PE Ratio = -94.88
Year | PE Ratio | Change |
---|---|---|
2023 | -2.73 | -69.93% |
2022 | -9.06 | -90.45% |
2021 | -94.88 | 75.81% |
2020 | -53.97 | -28.73% |
2019 | -75.73 | -5.51% |
2018 | -80.15 | 377.46% |
2017 | -16.79 | -23.14% |
2016 | -21.84 | -0.76% |
2015 | -22.01 | 335.85% |
2014 | -5.05 | 289.61% |
The current PE Ratio of Codexis, Inc. (CDXS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-35.56
5-year avg
-47.27
10-year avg
-38.22
Codexis, Inc.’s PE Ratio is less than Nuvation Bio Inc. (-1.34), less than Lyell Immunopharma, Inc. (-1.42), less than Century Therapeutics, Inc. (-0.91), less than Generation Bio Co. (-0.92), less than Shattuck Labs, Inc. (-2.08), greater than Foghorn Therapeutics Inc. (-4.49), greater than Monte Rosa Therapeutics, Inc. (-3.11), greater than Kymera Therapeutics, Inc. (-21.01), greater than Nurix Therapeutics, Inc. (-8.82), less than Kezar Life Sciences, Inc. (-0.41), greater than Mineralys Therapeutics, Inc. (-4.63), greater than Nkarta, Inc. (-3.62), less than NGM Biopharmaceuticals, Inc. (-0.91), greater than Cullinan Oncology, Inc. (-6.96), greater than Theseus Pharmaceuticals, Inc. (-3.19), greater than Revolution Medicines, Inc. (-13.31),
Company | PE Ratio | Market cap |
---|---|---|
-1.34 | $692.60M | |
-1.42 | $299.52M | |
-0.91 | $123.69M | |
-0.92 | $145.50M | |
-2.08 | $167.05M | |
-4.49 | $416.63M | |
-3.11 | $349.21M | |
-21.01 | $2.89B | |
-8.82 | $1.50B | |
-0.41 | $40.82M | |
-4.63 | $558.43M | |
-3.62 | $375.37M | |
-0.91 | $128.53M | |
-6.96 | $1.04B | |
-3.19 | $181.50M | |
-13.31 | $6.99B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Codexis, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Codexis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Codexis, Inc.'s PE Ratio?
How is the PE Ratio calculated for Codexis, Inc. (CDXS)?
What is the highest PE Ratio for Codexis, Inc. (CDXS)?
What is the 3-year average PE Ratio for Codexis, Inc. (CDXS)?
What is the 5-year average PE Ratio for Codexis, Inc. (CDXS)?
How does the current PE Ratio for Codexis, Inc. (CDXS) compare to its historical average?